Adverum Biotechnologies, Inc.
ADVM
$4.18
$0.010.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -97.09% | 29.14% | |||
| Gross Profit | 97.09% | -29.14% | |||
| SG&A Expenses | -28.44% | -34.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.67% | 3.39% | |||
| Operating Income | 3.67% | -3.39% | |||
| Income Before Tax | 3.13% | -4.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.13% | -4.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.13% | -4.62% | |||
| EBIT | 3.67% | -3.39% | |||
| EBITDA | 3.57% | -3.75% | |||
| EPS Basic | 13.34% | -4.26% | |||
| Normalized Basic EPS | 13.35% | -4.26% | |||
| EPS Diluted | 13.34% | -4.26% | |||
| Normalized Diluted EPS | 13.35% | -4.26% | |||
| Average Basic Shares Outstanding | 11.79% | 0.34% | |||
| Average Diluted Shares Outstanding | 11.79% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||